{"organizations": [], "uuid": "edccd77e919053a4486673bc2ca0652e9a576a5a", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.reuters.com", "main_image": "https://s2.reutersmedia.net/resources/r/?m=02&d=20180308&t=2&i=1238673391&w=1200&r=LYNXNPEE270FE", "site_section": "http://feeds.reuters.com/reuters/UKHealthNews", "section_title": "Reuters: Health News", "url": "https://uk.reuters.com/article/us-sanofi-evotec/sanofi-evotec-team-up-for-research-on-infectious-diseases-treatment-idUKKCN1GK0OL", "country": "US", "domain_rank": 408, "title": "Sanofi, Evotec team up for research on infectious diseases treatment", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-08T09:04:00.000+02:00", "replies_count": 0, "uuid": "edccd77e919053a4486673bc2ca0652e9a576a5a"}, "author": "", "url": "https://uk.reuters.com/article/us-sanofi-evotec/sanofi-evotec-team-up-for-research-on-infectious-diseases-treatment-idUKKCN1GK0OL", "ord_in_thread": 0, "title": "Sanofi, Evotec team up for research on infectious diseases treatment", "locations": [], "entities": {"persons": [{"name": "sudip kar-gupta", "sentiment": "none"}, {"name": "evotec", "sentiment": "none"}, {"name": "gopakumar warrier", "sentiment": "none"}], "locations": [{"name": "evotec", "sentiment": "none"}, {"name": "france", "sentiment": "none"}, {"name": "paris", "sentiment": "none"}, {"name": "paris", "sentiment": "none"}], "organizations": [{"name": "sanofi", "sentiment": "negative"}, {"name": "evotec", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 8, 2018 / 7:08 AM / Updated 14 hours ago Sanofi, Evotec team up for research on infectious diseases treatment Reuters Staff 1 Min Read PARIS (Reuters) - Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on Thursday that they would form a new open innovation platform in this area, led by Evotec. FILE PHOTO: French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo Sanofi will license its research into infectious diseases and its early-stage development portfolio, and the French group will also transfer its research unit dealing with this area over to Evotec. Sanofi will pay Evotec an initial one-time cash upfront payment of 60 million euros ($74.4 million) and provide further significant long-term funding to develop portfolio, the companies added. Reporting by Sudip Kar-Gupta; Editing by Gopakumar Warrier", "external_links": [], "published": "2018-03-08T09:04:00.000+02:00", "crawled": "2018-03-08T16:14:03.002+02:00", "highlightTitle": ""}